(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIÇÃO COMBINADA DE PD-1, TGFSS E ATM JUNTAMENTE COM RADIOTERAPIA PARA O TRATAMENTO DE CÂNCER

ArquivadaInvention PatentPCT · EP2020080682

Application data

Number

112022007787

Type

Invention Patent

Filing

11/02/2020

Publication

07/05/2022

PCT

EP2020080682

Progress at the INPI

  1. Filing11/02/20
  2. Publication07/05/22
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 11/02/2020 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 02/06/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ARES TRADING S.A.

CH

GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 4) LTD.

GB

See this company's full portfolio

Inventors

A. L. (pessoa física)

US

Y. L. (pessoa física)

US

Technical data

Priority claims

US

62/929,379 · 11/01/2019

Abstract

INIBIÇÃO COMBINADA DE PD-1, TGFB E ATM JUNTAMENTE COM RADIOTERAPIA PARA O TRATAMENTO DE CÂNCER. A presente invenção refere-se a terapias de combinação úteis para o tratamento de câncer. Em particular, a invenção refere-se ao uso combinado de um inibidor de PD-1, um inibidor de TGFß, um inibidor de ATM e radiação para tratar câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

02/06/2024

RPI 2770

Arquivamento - Art. 33 da LPI

#11.1

11/21/2023

RPI 2759

Notificação de entrada na fase nacional - PCT

#1.3

07/05/2022

RPI 2687

Alteração de dados cadastrais

#1.1

05/03/2022

RPI 2678

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.